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Background: HS-1-associated protein X-1 (Hax-1), is a multifunctional protein that has sequence homology to Bcl-2
family members. HAX-1 knockout animals reveal that it plays an essential protective role in the central nervous
system against various stresses. Homozygous mutations in the HAX-1 gene are associated with autosomal recessive
forms of severe congenital neutropenia along with neurological symptoms. The protein level of Hax-1 has been
shown to be regulated by cellular protease cleavage or by transcriptional suppression upon stimulation.
Results: Here, we report a novel post-translational mechanism for regulation of Hax-1 levels in mammalian cells.
We identified that PEST sequence, a sequence rich in proline, glutamic acid, serine and threonine, is responsible for
its poly-ubiquitination and rapid degradation. Hax-1 is conjugated by K48-linked ubiquitin chains and undergoes a
fast turnover by the proteasome system. A deletion mutant of Hax-1 that lacks the PEST sequence is more resistant
to the proteasomal degradation and exerts more protective effects against apoptotic stimuli than wild type Hax-1.
Conclusion: Our data indicate that Hax-1 is a short-lived protein and that its PEST sequence dependent fast
degradation by the proteasome may contribute to the rapid cellular responses upon different stimulations.
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HS-1-associated protein X-1, Hax-1, is a 35 kDa pro-
tein with two Bcl-2 homology (BH) domains that was
identified in a yeast two hybrid screen where it was
found to interact with HS-1, a Src kinase substrate [1].
Hax-1 is ubiquitously expressed in most tissues and
is reported to be localized in mitochondria as well as
the endoplasmic reticulum (ER) and nuclear membrane
[1-3]. Mutations identified in the human HAX-1 gene
have been shown to cause neutropenia and neurodeve-
lopmental abnormalities [4-6]. Knockout HAX-1 mice
show increased apoptosis of neurons and postnatal le-
thality. [7]. Hax-1 is a multifunctional protein that
plays roles in calcium homeostasis [8], cell migration
[9] and apoptotic regulation [10,11]. It was reported
that Hax-1 protects cells against various stimuli and
has been shown to interact with a number of cellular* Correspondence: wanggh@suda.edu.cn
1Laboratory of Molecular Neuropathology, Department of Pharmacology,
Soochow University College of Pharmaceutical Sciences, Suzhou, Jiangsu
201203, People's Republic of China
Full list of author information is available at the end of the article
© 2012 Li et al.; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the orand viral proteins to suppress their pro-death proper-
ties [12-15]. In addition, Hax-1 has been found to be
up-regulated in breast cancer, lung cancer and melan-
oma [16], suggesting that it also has a role in
oncogenesis.
A PEST sequence is a peptide sequence which is rich
in proline (P), glutamic acid (E), serine (S), and threo-
nine (T). It is known that the PEST sequence functions
as a proteolytic signal to target proteins for degradation
resulting in short intracellular half lives [17]. For
example, the PEST sequence of NF-kappa B is respon-
sible for its cleavage by calpain [18]. It was reported that
c-myc, a protein with a PEST sequence, has a half-life
shorter than one hour [17]. Notch 1, another short-lived
protein, is ubiquitinated by an E3 ligase sel-10 and
degraded by the proteasome dependent on its PEST se-
quence [19,20].
Hax-1 was predicted to contain a PEST sequence
(aa 104–117) [1], however, it is still unknown whether
this PEST sequence effects its turnover rate. In this
study, we investigated the stability of Hax-1 in differ-
ent cells and explored the role of the PEST sequence
in its degradation and biological function.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 (See legend on next page.)
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Figure 1 Rapid degradation of Hax-1 is dependent on its PEST sequence. A. Schematic representation of a PEST sequence in Hax-1 protein.
The PEST sequence was identified using Pestfind service on “emboss.bioinformatics.nl/cgi-bin/emboss/pestfind”. The PEST sequence in Hax-1 is
conserved among different mammals. B. Chase-time experiment of Hax-1 and other Bcl-2 proteins. H1299 cells treated with CHX (100 ug/ml) for
different time points were harvested for immunoblot analysis using indicated antibodies. C. Data from three independent experiments in B were
quantified. D. Similar experiments as B were carried out using mouse N2a cells. E. An EGFP-tagged WT Hax-1 or ΔPEST Hax-1 was transiently
transfected into H1299 cells. Forty-eight hours later, CHX chase experiments were carried out. F. Quantitative analysis of data from E with three
independent experiments.
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Rapid degradation of Hax-1
In addition to its BH domains and a trans-membrane
domain, Hax-1 has a PEST sequence [1]. The PEST re-
gion in Hax-1 is highly conserved in mammalian animals
(Figure 1A). We tested the degradation profile of Hax-1
using a cycloheximide (CHX) chase experiment in both
human lung cancer cell line H1299 and mouse neuro-
blastoma cell line N2a. Hax-1 was found to have a much
shorter half-life than other two pro-survival Bcl-2 family
proteins, Bcl-2 and Bcl-xL (Figure 1B-D), suggesting that
the Hax-1 protein is unstable and is rapidly degraded.
PEST sequence-dependent degradation of Hax-1
We next tested whether the PEST sequence in Hax-1 is
responsible for its rapid degradation. A deletion mutant
of Hax-1 was constructed in which the PEST sequence
(aa 103–118) was deleted. The CHX chase experiments
showed that the ΔPEST Hax-1 level remained largely
unchanged up to 3 hours, whereas WT Hax-1 level rap-
idly decreased to< 50 % within 3 hours (Figure 1E and
F), suggesting that the PEST sequence in Hax-1 is neces-
sary for its rapid degradation.
Degradation of Hax-1 by the ubiquitin-proteasome
pathway
Proteasome and autophagy systems are two main path-
ways for protein degradation. Here we tested which
pathway is involved in the fast-turnover of Hax-1. Cells
were treated with MG132, a proteasome inhibitor, or
Bafilomycin A1, an autophagy inhibitor. The level of
EGFP-Hax-1 increased in cells treated with MG132 for 3
hours (Figure 2A), whereas in cells treated with Bafilo-
mycin A1 the protein level remained unchanged up to
18 hours (Figure 2B). These data suggest that Hax-1 is
mainly degraded by the proteasome, but not by
autophagy-lysosome pathway. A time-dependent in-
crease in endogenous Hax-1 level was also observed in
cells treated with MG132 (Figure 2C). We next exam-
ined the turnover of endogenous Hax-1 in the presence
of MG132 using CHX chase experiments. In the pres-
ence of MG132, endogenous Hax-1 was not observed to
be degraded within 4 hours, however, in the absence of
MG132, it was rapidly degraded after two hours
(Figure 2D).Hax-1 conjugation with K48-linked ubiquitin chains is
dependent on the PEST sequence
We have shown that Hax-1 is degraded by the prote-
asome. Usually, the proteasomal degradation process
requires polyubiquitination of the substrates [21]. We
therefore tested if Hax-1 is ubiquitinated and if yes,
what kind of ubiquitin conjugation is involved in the
degradation of Hax-1. Enhanced ubiquitination of
Hax-1 was observed in the presence of MG132 than
that in the absence of MG132 (Figure 3A) as revealed
by co-immunoprecipitation experiments. Then, we
examined the polyubiquitin of Hax-1 with two specific
antibodies which recognize K48- or K63-linked ubiqui-
tin, respectively. Increased polyubiquitination of Hax-1
was detected with an antibody specific to K48-linked
polyubiquitin, but not with that to K63-linked polyubi-
quitin (Figure 3B), suggesting that Hax-1 is mainly
conjugated by the K48-linked ubiquitin chains. We
next evaluated if the PEST sequence affects Hax-1
polyubiquitination. We found that the deletion of the
PEST sequence in Hax-1 greatly decreased its polyubi-
quitination (Figure 3C), suggesting that the PEST se-
quence in Hax-1 is necessary for its ubiquitination.
Increased degradation of Hax-1 during apoptosis
As Hax-1 is known to be an anti-apoptotic protein, we
hypothesized whether its degradation is regulated under
apoptosis. We transfected H1299 cells with EGFP-Hax-1
and treated them with DMSO or staurosporine (STS),
an inducer of apoptosis. In the absence of MG132, the
amounts of Hax-1 protein decreased with increasing
concentration of STS, however, in the presence of
MG132, the trend was largely attenuated (Figure 3D and
E), suggesting an accelerated degradation of Hax-1 by
the proteasome under apoptosis.
ΔPEST Hax-1 mutant attenuated STS-induced cell death
As overexpression of Hax-1 has been shown to have an
anti-apoptotic effect and also regulates mitochondria
membrane potential [10], we examined the effects of
knockdown of Hax-1 on STS-induced apoptosis. The ef-
ficacy of the siRNA against Hax-1 was evaluated
(Figure 4A). STS induced significantly higher level of
apoptosis in those cells in which Hax-1 levels were
knocked down as compared to control cells. This
Figure 2 (See legend on next page.)
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Figure 2 Proteasomal degradation of Hax-1. A and B. H1299 cells were transiently transfected with EGFP-Hax-1. Forty-eight hours later, cells
were treated with MG132 (1 μM) for 3 hours (A) or Bafilomycin A1 (10 nM) for 18 hours (B). Cells were then harvested and immunoblotted using
anti-GFP, ubiquitin, LC3 or GAPDH antibody. Detections of polyubiquitin (A, left, lower panel) and LC3-II (B, left, lower panel) levels in input were
used to indicate polyubiquitination levels (A) and autophagy levels (B). Data from three independent experiments were quantified (means± S.E.M.,
*p< 0.05, one-way ANOVA). C. Time dependent increase of Hax-1 levels by the proteasomal inhibition (Upper panel). Increased levels of total
ubiquitin were served as positive controls for MG132 treatment. Tubulin was served as loading control. D. H1299 cells were treated with CHX
with or without MG132 for chase experiments.
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dosage (Figure 4B). Using JC-1 (a lipophilic, cationic dye
that selectively enters into mitochondria and reversibly
changes its color from green to red as the membrane
potential increases) staining, we found that mitochon-
drial potential was also greatly decreased in Hax-1
knockdown cells than in control cells upon CCCP (Car-
bonyl cyanide m-chlorophenyl hydrazone, an inducer to
cause mitochondrial permeability transition) treatment
(Figure 4C). These data indicate that Hax-1 is important
for cells against apoptotic stress or mitochondrial dam-
age. We next transfected cells with WT Hax-1 or ΔPEST
Hax-1 and then treated cells with STS. Fewer condensed
nuclei were observed in EGFP-ΔPEST Hax-1 expressing
cells than in EGFP-Hax-1 expressing cells (Figure 4D
and E), suggesting that deletion of PEST sequence may
increase Hax-1 stability, causing more resistance to STS-
induced apoptosis.Discussion
Hax-1 transcript levels in mouse kidney, testis, and liver
have previously been found to not directly correlate with
detected protein levels [22]. Similar phenomenon has
also been observed in rat tissues [23]. Two hypotheses
to explain the different levels of mRNA compared to
protein are that either high amounts of the Hax-1 tran-
script do not translate into proteins or that the protein
degradation rate of Hax-1 is considerably high [24].
Here, we provide clear evidence showing that Hax-1
protein is indeed turned over at a fast rate in a proteo-
some dependent manner. It is important to note that,
Hax-1 exists as many as 7 alternative splicing forms
[16,23], and these splicing variants may play important
roles in development or tumor formation. For example,
the internal deletions in variants vII, vIV and vVI result
in removal of BH domains and changes in PEST domain
from variants I (the full length 278aa form which is
investigated in this paper) [23]. It is therefore possible
that these variant forms of Hax-1, because of its impair-
ment in PEST degradation signal, is more stable than its
dominant form variant I. The population of cells bearing
an up-regulation of these variants shows enhanced pro-
tective roles in tissues or more oncogenic activity, as evi-
denced in tumors [16].Polyubiquitination is required for the protein degrad-
ation by the proteasome [21]. Ubiquitin molecules,
which form ubiquitin chains to a protein, are covalently
linked to each other between a lysine site (K11, K29,
K48 or K63) of the previous ubiquitin and the carboxy-
terminal glycine of a new ubiquitin. K48-linked polyubi-
quitination of a protein usually mediates its degradation
by the proteasome, however, K63-linked polyubiquitina-
tion is most likely to play roles in translation, endocyto-
sis and other functions [25-27]. In the present report,
we demonstrate that Hax-1 is ubiquitinated via K48-
linked ubiquitin chains. The ubiquitination of Hax-1 is
largely dependent on its PEST sequence. In many short-
lived proteins, the PEST sequence serves as a signal se-
quence to drive their proteolysis or rapid degradation
[17]. In some cases, ubiquitination of proteins depends
upon their PEST sequence [19]. Here, we found that de-
letion of the PEST sequence results in much less ubi-
quitination of Hax-1, thereby increasing its stability. It
is therefore possible that the PEST sequence in Hax-1 is
responsible for its proper folding to be conjugated with
the ubiquitin chains. The PEST sequence is also
reported to be a motif that is involved in protein modi-
fication. For example, phosphorylation of a PEST se-
quence by casein kinase II (CKII) appears to promote
the degradation of IκBα [28]. Also, a PEST-like se-
quence has been shown to mediate phosphorylation
and efficient ubiquitination of yeast uracil permease
[29]. Further studies to identify if the PEST sequence in
Hax-1 is phosphorylated and if this modification affects
Hax-1 stability will be of help to explore the exact role
of the PEST sequence in Hax-1.
Hax-1 is structurally similar to Bcl-2 for its BH
domains and TM domain. However, Hax-1 is less stable
compared to other Bcl-2 family proteins [30,31]. It was
reported that Hax-1 is rapidly cleaved by caspase 3 [32],
HtrA2 [10] or Granzyme B [33] during cell death. It is
therefore possible that these enzymes contribute to
Hax-1 degradation in apoptosis. As Hax-1 is a short-
lived protein and also degraded by the proteasome, it
suggests that the proteasomal degradation of Hax-1
highly regulates Hax-1 levels in normal conditions.
Knockdown of pleiotropic human prohibitin 2 in HeLa
cells results in caspase-dependent apoptosis through
down-regulation of Hax-1 [34]. Here, we report that, in
addition to protease cleavage, the proteasomal degrad-
ation is also an important post-translational regulation
Figure 3 (See legend on next page.)
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Figure 3 K48-linked ubiquitiniation of Hax-1 enhanced proteasomal degradation of Hax-1 during apoptosis. A. H1299 cells were
transfected with EGFP or EGFP-Hax-1. Forty-eight hours later, cells were treated with or without MG132 (1 μM) for 12 hours. Cell lysates were then
subjected to immunoprecipitation with anti-GFP antibodies and the immunoprecipitants were detected with total ubiquitin antibody. B. Similar
experiments as A were performed using specific anti-K48 or -K63 ubiquitin antibodies. C. H1299 cells were transfected with EGFP or EGFP-Hax-1
or EGFP-ΔPEST Hax-1 expression constructs. Forty-eight hours later, cells were treated with MG132 (1 μM) for 12 hours. Cell lysates were then
immunoprecipitated with anti-GFP antibodies and detected with anti-K48 ubiquitin antibodies. D. EGFP-Hax-1 transfected H1299 cells were
treated with DMSO or increased levels of STS (0.2-1 μmol) in the absence or presence of MG132 for 3 hours. Cells were then harvested and
subjected to immunoblot analysis with anti-GFP antibody. E. Quantitative analyses of Hax-1 degradation upon STS treatment through three
independent experiments were shown.
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the PEST sequence is abolished, Hax-1 is shown to con-
vey increased resistance to cell death. Taken together,
these data suggest that Hax-1 may be rapidly subjected
to proteolysis in response to cellular stresses, resulting
in a decrease in its protein level and hence loss of its
protective activity.
Conclusions
In summary, our study demonstrates that Hax-1 is
rapidly degraded by the proteasome in a PEST se-
quence dependent manner. During apoptosis, degrad-
ation of Hax-1 is enhanced whereas expression of
ΔPEST mutant of Hax-1 protects cells against apop-
totic stimulation.
Methods
Cell culture, transfections and drug treatments
N2a and H1299 cells were grown in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM, GIBCO) containing
10 % fetal calf serum with 100 μg/ml penicillin and
100 μg/ml streptomycin. Transfections were performed
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. In order to ensure equal
transfection efficiency, master mix of the same plas-
mids were made and aliquot to each well, we double
check the equal expression of EGFP-Hax-1 through
fluoresce microscopy before drug treatment (by deem
to lowest exposure). Hoechst 33342, DAPI, STS (Staur-
osporine), Bafilomycin A1, Annexin V, PI (Propidium
iodide) and CHX (cycloheximide) were purchased from
Sigma. MG132 was obtained from Calbiochem.
Plasmids
The Hax-1 related constructs were described previously
[35]. A PEST sequence deletion mutant was created using
the following primers: 5’-ACCAAGATCACTAAACCA-3’
and 5’-CTGTAGAACCGGGCCAAG-3’.
siRNAs
35 pmoles of each siRNA were transfected using Oligo-
fectamine, according to the manufacturer’s instructions










Immunoblot analysis and antibodies
Cell extracts were lysed in 1 × RIPA lysis buffer
(25 mM Tris–HCl, pH 7.6, 150 mM NaCl, 1 % NP-40
and 1 % sodium deoxycholate) in the presence of pro-
tease inhibitor cocktail (Roche). Approximately 20 μg
of cell lysates was separated on SDS-PAGE and trans-
ferred onto a PVDF membrane (Millipore). Immuno-
blot analyses were carried out with the following
primary antibodies: anti-Bcl-2 (Abcam), anti-Bcl-xL
(Cell Signaling Technology), anti-GAPDH (Chemicon),
anti-GFP (Santa Cruz Biotechnology), anti-LC3
(Novas), anti-Tubulin (Merck Chemicals), anti-Hax-1
(BD Biosciences), anti-Flag (Sigma), anti-ubiquitin
(Santa Cruz Biotechnology), anti-K48-ubiquitin (Milli-
pore) and anti-K63-ubiquitin (Millipore). The second-
ary antibodies, i.e., sheep anti-mouse IgG-HRP or
anti-rabbit IgG-HRP, were from Amersham Pharmacia
Biotech. The proteins were visualized using an ECL
detection kit (Amersham Pharmacia Biotech).
Immunoprecipitation
Cells transfected with the indicated plasmids were col-
lected 48 hrs after transfection and were lysed in TSPI
buffer containing 50 mM Tris–HCl, pH 7.5, 150 mM so-
dium chloride, 1 mM EDTA and 1 % NP-40 supplemen-
ted with complete mini protease inhibitor cocktail
(Roche). Cellular debris was removed by centrifugation
at 12,000 g for 30 minutes at 4°C. The supernatants were
incubated with anti-GFP antibodies overnight at 4°C.
After incubation, protein G Sepharose (Roche) was used
for precipitation. The beads were washed with TSPI
Figure 4 ΔPEST Hax-1 strongly attenuates apoptosis. A. Knockdown efficiency of Hax-1 siRNA used in this study. B. H1299 cells were
transfected with negative control (NC) or siRNA against Hax-1 and then treated with different doses of STS (2–10 nM) for 2 hours. Cells were
double stained with annexin V-FITC and PI followed by FACS analyses. C. H1299 cells were transfected with NC or siRNA against Hax-1 and then
treated with CCCP (10 μM) for 30 minutes. After CCCP treatment, cells were stained with a JC-1 mitochondrial membrane potential detection kit.
D. H1299 cells were transfected with EGFP or EGFP-Hax-1 or EGFP-ΔPEST Hax-1. Forty-eight hours later, cells were treated with STS (20 nM) for 12
hours and stained with Hoechst 33342. E. Quantitative analysis of condensed nuclei from D with three independent experiments was performed;
random field of 250 cells were counted. (means ± S.E.M., *p< 0.05, one-way ANOVA).
Li et al. BMC Cell Biology 2012, 13:20 Page 8 of 10
http://www.biomedcentral.com/1471-2121/13/20buffer four times and then eluted with SDS sample buf-
fer for immunoblot analysis.
Statistical analysis
Densitometric analysis of immunoblots from three inde-
pendent experiments was performed using ImageJ windowsversion. The data were analyzed using windows version of
Origin 6.0 (Originlab) or Prism 5 (Graphpad softwere). The
pictures in Figure 1A were draw using DOG 1.0 [36].
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